BioSpace News Archive

Cancer-killing virus boosts immunotherapy in hard-to-treat cancer

Combining a cancer-killing virus with immunotherapy could effectively treat advanced cancers that affect the limbs, a new study reveals.

June 18, 2019
·
6 min read
Business

Amgen’s deCODE and Intermountain Healthcare to Run 500,000 Patient DNA Study

Amgen hopes the data will provide insights into specific diseases that will help develop new drugs.

June 18, 2019
·
2 min read
·
Mark Terry
Policy

India’s Pharmaceutical Business Could Benefit from the Sino-American Trade Conflict

Trade tensions between Washington, D.C. and Beijing continue, but have not yet impacted the pharmaceutical products traded between the two countries. However, if the punitive tariffs continue and pharma is impacted, a third global player could step in to fill the void in both countries.

June 18, 2019
·
3 min read
·
Alex Keown
Drug Development

Amarantus Announces Positive Pre-Clinical Data for MANF in Wolfram Syndrome Presented at the 79th Annual Scientific Sessions of the American Diabetes Association

Amarantus Bioscience Holdings, Inc. announced that positive results from in vitro and animal studies on MANF in the treatment of Wolfram Syndrome were presented at the 79th Annual Scientific Sessions of the American Diabetes Association.

June 18, 2019
·
5 min read
Genetown

CENTOGENE Accelerates Rare Disease Diagnosis with new Artificial Intelligence Solution

Variant Prioritization Tool Driven by World’s Largest Curated Mutation Database

June 18, 2019
·
2 min read
Biotech Bay

MyoKardia to Present at 2019 BMO Prescriptions for Success Healthcare Conference

MyoKardia, Inc. announced that Jake Bauer, Chief Business Officer, will participate in a fireside chat at the 2019 BMO Prescriptions for Success Healthcare Conference on Tuesday, June 25th, 2019, at 1:20 p.m. ET in New York, NY.

June 18, 2019
·
2 min read
Drug Development

Medigene AG: Interim analysis from ongoing Phase I/II clinical trial with DC vaccines in AML patients presented at EHA

Medigene AG announced that clinical data from the interim analysis of the ongoing Phase I / II clinical trial with Medigene’s DC vaccine for the treatment of acute myeloid leukemia was presented during the annual congress of the European Hematology Association taking place from 13 - 16 June in Amsterdam.

June 18, 2019
·
6 min read
Business

Sanofi and Google Partner on Digital Health and Real-World Evidence Analysis

Google and Sanofi are partnering to set up a new virtual innovation lab with a focus on data technologies and digital health. The goal is to change how Sanofi develops new drugs.

June 18, 2019
·
3 min read
·
Mark Terry
Business

SpringWorks and BeiGene Team Up to Form New Company

The companies will combine their research expertise to develop BGB-3245, an investigational, oral, selective small molecule inhibitor of monomer and dimer forms of activating B-RAF mutations including V600 BRAF mutations, non-V600 B-RAF mutations, and RAF fusions.

June 18, 2019
·
2 min read
·
Alex Keown
BioForest

CytoDyn Announces Major Discovery for its Monotherapy Indication

CytoDyn and IncellDx Report the Successful Development and Validation of an Assay to Assess the Responders for Monotherapy HIV Patients

June 18, 2019
·
8 min read